聊天GPT和双子座在华法林咨询咨询中
Muhammet Hüseyin Erkan1, Ömer Faruk Rahman, Abdullah Güner
1Muhammet Hüseyin Erkan, Department of Cardiovascular Surgery, Balikesir University, Bigadic, 10145 Balikesir, Turkey, mhuseyinerkan@gmail.com.
Croatian medical journal
|January 11, 2026
概括
聊天GPT和双子座提供可靠的华法林咨询信息. 聊天GPT提供了更科学充分的反应,而双子座在患者理解的清晰度方面表现出色. 专家指导对于安全使用至关重要.
科学领域:
- 人工智能在医学中的应用
- 医疗信息传播 医疗信息传播
背景情况:
- 华法林 (一种血液稀释剂) 需要明确的患者咨询.
- 像ChatGPT和Gemini这样的大型语言模型 (LLM) 越来越多地用于健康信息.
研究的目的:
- 为了比较ChatGPT-4o和双子座对华法林使用的反应,以获得准确性,科学充分性和清晰性.
- 评估LLM生成的患者信息的临床实用性.
主要方法:
- 关于华法林使用的40个患者问题被提出给ChatGPT和Gemini.
- 四位心血管外科医生使用5点的利克特度表来评估反应的充分性,准确性和清晰度.
- 采用了一个盲目的,零射击的评估方法.
主要成果:
- 聊天GPT的反应较短,但在科学上更充分 (P=0.004).
- 双子座显示出更高的清晰度 (P<0.001).
- 两种模型之间的准确性没有显著差异 (P=0.606).
结论:
- 这两种LLM都提供了可靠的华法林咨询信息.
- 聊天GPT提供详细的科学内容;双子座优先考虑用户友好的清晰度.
- 专家监督对于安全和全面的患者指导至关重要.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
191
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
191
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Therapeutic Drug Monitoring: Affecting Factors
193
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
193


